FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine, pharmacology and biology, and concerns application of trecresan as a total tryptophanyl-tRNA synthetase (TRSase) activator.
EFFECT: high-active agent ensuring higher cholesterol resistance of the vascular system is developed.
2 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| APPLICATION OF PROTATRANE 4-CHLORO-2-METHYLPHENOXIACETATE (CHLORCREZACINE) FOR TRYPTOPHANYL-tRNA-SYNTHETASE MATRIX RNA EXPRESSION STIMULATION | 2016 |
|
RU2623035C1 |
| AGENT STIMULATING EXPRESSION OF MATRIX RNA OF TRYPTOPHANYL-tRNA-SYNTHETASE | 2010 |
|
RU2429836C1 |
| HERMATRANOL HYDRATE STIMULATING TRYPTOPHANYL-TRNA-SYNTHETASE MATRIX RNA EXPRESSION | 2014 |
|
RU2553986C1 |
| USING ZINC COMPLEX-TRIS-(2-HYDROXYETHYL)AMINE WITH BIS-(2-METHYLPHENOXYACETATE) (ZINCATRANE) FOR STIMULATING EXPRESSION OF MATRIX RNA OF TRYPTOPHANYL-tRNA-SYNTHETASE | 2014 |
|
RU2540469C1 |
| COMPLEX OF TRIS-(2-HYDROXYETHYL)AMINE WITH ZINK BIS-(2-METHYLPHENOXYACETATE), INCREASING CYTOKIN ACTIVITY OF TOTAL TRIPTOPHANYL-tRNA-SYNTHETASE | 2011 |
|
RU2457837C1 |
| METHOD TO PRODUCE MODIFIED FORM OF TRYPTOPHANYL-tRNA-SYNTHETASE | 2012 |
|
RU2495123C2 |
| USING COMPLEX OF TRIS-(2-HYDROXYETHYL)AMINE AND ZINC BIS-(2-METHYLPHENOXYACETATE) (CINKATRAN) AS AGENT SUPPRESSING TOTAL ACTIVITY OF BASIC (ALKALINE) MONONUCLEAR PHOSPHOLIPASE A2 | 2014 |
|
RU2546537C1 |
| USING COMPLEX OF TRIS-(2-HYDROXYETHYL)AMINE AND ZINC BIS-(2-METHYLPHENOXY-ACETATE) (ZINCATRAN) AS HYPOLIPIDEMIC (ANTIATHEROSCLEROTIC) AGENT | 2014 |
|
RU2575788C1 |
| AGENT TO DECREASE CHOLESTEROL ESTERASE ACTIVITY | 2010 |
|
RU2444357C1 |
| USING PROTATRAN 4-CHLOR-2-METHYLPHENOXYACETATE (CHLORCRESACIN) FOR ARREST OF CHOLESTEROLESTERASE ACTIVITY | 2014 |
|
RU2563831C1 |
